Skip to main content
. 2019 Dec 27;9(4):2045894019894531. doi: 10.1177/2045894019894531

Table 3.

Clinical and hemodynamic parameters of the 259 analyzed subjects differentiated by survival status.

Survived Died pa
Number 150 109
Age (years) 62 ± 14 69 ± 10 <0.001
6-minute walk distance 373 ± 115 297 ± 92 <0.001
NT pro-BNP (pg/ml) 1250 ± 1792 2121 ± 2027 0.001
TAPSE (mm) 19.0 ± 4.9 17.2 ± 4.7 0.008
DLCO (% predicted) 55 ± 21 41 ± 20 <0.001
Mean PAP at Dx (mmHg) 42 ± 11 42 ± 11 0.946
PAWP Dx (mmHg) 10 ± 6 10 ± 5 0.565
PVR Dx (WU) 7.2 ± 4.3 7.5 ± 4.3 0.620
CO Dx (l/min) 5.0 ± 1.6 4.7 ± 1.4 0.098
Innocor-PBF (l/min) 4.4 ± 1.4 4.1 ± 1.3 0.108
Innocor-PBF (l/min/m2) 2.3 ± 0.6 2.3 ± 0.6 0.556
Time between Dx of PH and PBF measurement 8 [0; 42] 9 [0; 29] 0.020

Note: Results are provided as mean ± standard deviation.

CO: cardiac output; DLCO: diffusion capacity of the lung for carbon monoxide; Dx: diagnosis; PAP: pulmonary arterial pressure; PAWP: pulmonary arterial wedge pressure; PBF: pulmonary blood flow; PH: pulmonary hypertension; PVR: pulmonary vascular resistance; TAPSE: tricuspid annular plane systolic excursion; WU: Wood unit.

a

Difference between the groups (t-test for continuous variables).